Sanderling Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
156
- Portfolio
-
8
- Exits
-
72
Sanderling Ventures General Information
Company Description
Founded in 1979, Sanderling Ventures is a venture capital firm based in San Mateo, California. The firm prefers to invest in the biomedical industry, focusing on companies operating in the biotechnology, life sciences, therapeutics & pharmaceuticals, biologics & vaccines, drug delivery, platform technologies, medical devices & instrumentation, diagnostics, medical informatics, healthcare information technology, eHealth, and healthcare services sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.sanderling.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 1300 South El Camino Real
- Suite 203
- San Mateo, CA 94402
- United States
Sanderling Ventures Investments & Acquisitions (156)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Glycomine | 14-May-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Glycomine | 11-Jun-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| ViaCyte | 09-Jun-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| CalciMedica | 11-Mar-2021 | Drug Discovery | Generating Revenue | |||
| ViaCyte | 26-May-2020 | Drug Discovery | Clinical Trials - Phase 2 | |||
| CalciMedica | 22-May-2020 | Drug Discovery | Generating Revenue | |||
| Tavec Pharmaceuticals | 10-May-2019 | Biotechnology | Out of Business | |||
| Metavention | 15-Dec-2017 | Therapeutic Devices | Generating Revenue | |||
| SpecificiT Pharma | 23-Aug-2017 | Seed Round | Biotechnology | Out of Business | ||
| PreciThera | 27-Jul-2017 | Early Stage VC | Drug Discovery | Pre-Clinical Trials |
Sanderling Ventures Exits (72)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| DalCor Pharmaceuticals | 01-May-2026 | Secondary Transaction - Private | |
| CalciMedica | 21-Mar-2023 | ||
| ViaCyte | 27-Sep-2022 | ||
| Sotera | 11-Jul-2022 | ||
| Therillia | 01-Jul-2022 | ||
| SpecificiT Pharma | 31-Dec-2021 | ||
| Diazon Pharmaceuticals | 23-Dec-2021 | ||
| Tavec Pharmaceuticals | 26-Oct-2021 | ||
| Artielle ImmunoTherapeutics | 01-Feb-2021 | Secondary Transaction - Private | |
| Lineagen | 21-Aug-2020 | Merger/Acquisition |
Sanderling Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Sanderling Ventures Investments by Industry, Year, and Region
Sanderling Ventures Co-Investors (11)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Aberdeen Investments (Scotland) | 1 |
|
|
||
| Abingworth |
|
|
|||
| CTI Life Sciences Fund |
|
|
|||
| Novo Holdings |
|
|
|||
| RiverVest Venture Partners |
|
|
Sanderling Ventures FAQs
-
What is Sanderling Ventures?
Founded in 1979, Sanderling Ventures is a venture capital firm based in San Mateo, California.
-
When was Sanderling Ventures founded?
Sanderling Ventures was founded in 1979.
-
Where is Sanderling Ventures headquartered?
Sanderling Ventures is headquartered in San Mateo, CA.
-
What is Sanderling Ventures's total asset value?
Sanderling Ventures has around in total assets under management.
-
How many investments has Sanderling Ventures made?
Sanderling Ventures has made 156 investments.
-
What has Sanderling Ventures invested in?
Sanderling Ventures has made numerous investments in companies like Glycomine, ViaCyte, and CalciMedica within the Drug Discovery industry.
-
What has Sanderling Ventures invested in recently?
Sanderling Ventures's latest investment was on 14-May-2026 in Glycomine, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process